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Abstract
For detection of small pancreatic tumors and characterization of focal pancreatic masses, endoscopic ultrasound (EUS) is
the most sensitive of the imaging procedures currently available. Differential diagnosis between benign and malignant focal
pancreatic masses based on the EUS appearance is difﬁcult and frequently requires EUS-guided ﬁne needle aspiration (EUS-
FNA) for conﬁrmation of malignancy. New techniques improve the sensitivity, speciﬁcity, and accuracy of the differential
diagnosis, as well as diagnosis of small pancreatic tumors (less than 2 cm diameter) by using real-time elastography or
contrast-enhanced EUS. Nevertheless, EUS-FNA is still required for the ﬁnal diagnosis in most of the cases, which allows an
evidence-based management with referral to either curative surgery or palliative chemoradiotherapy. This article is part of
an expert video encyclopedia.
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Materials
• Echoendoscope: EG-3870 UTK; Hoya/Pentax Corporation,
Tokyo, Japan.
• Ultrasound system: HV-Preirus; Hitachi Medical Corpor-
ation, Tokyo, Japan.
• Fine needle aspiration system: 22 G needle of 1400 mm,
EZ Shot (NA-200H-8022); Olympus, Tokyo, Japan.
Technique
Endoscopic ultrasound (EUS) procedures begin after patient’s
anesthesia, with the echoendoscope inserted into the second
part of the duodenum. The head of the pancreas and uncinate
process are usually best viewed through the medial wall of the
duodenum. Then the echoendoscope is withdrawn in the
stomach, with the body and tail of the pancreas seen through
the posterior wall of the stomach. Both the parenchyma and
the ductal system are examined, with careful description of
pancreatic tissue characteristics, as well as visualization of the
main pancreatic duct and common bile duct.
If necessary, at the the end of the procedure, EUS-guided
ﬁne needle aspiration (EUS-FNA) is performed. Puncture as-
piration is EUS-guided via an echoendoscope with
longitudinal view, including examinations in power Doppler
mode (to avoid puncture of interposed vessels with possible
bleeding complications). A total of three to six passages are
performed, with the needle contents expelled on several glass
slides that are stained with various smears (Diff-Quik, Papa-
nicolaou, etc.); additional content may be collected to obtain
cell blocks.
Background and Endoscopic Procedures
Ductal pancreatic adenocarcinoma is the most common ma-
lignant pancreatic neoplasm as it accounts for more than 95%
of all malignant solid pancreatic tumors.1 For detection of
small pancreatic tumors and characterization of focal pan-
creatic masses, EUS, especially with the addition of EUS-FNA,
represents the most sensitive and speciﬁc of the imaging
procedures currently available.1,2 Available EUS devices in-
clude radial and linear echoendoscopes, as well as thin cath-
eter ultrasound probes. EUS has various applications, such as
staging of gastrointestinal malignancy and evaluation of sub-
mucosal tumors, and has developed into an important mo-
dality for the assessment of the pancreaticobiliary system.
Pancreatic adenocarcinomas typically have the EUS ap-
pearance of a heterogeneous, hypoechoic mass with irregular
margins.1 Differential diagnosis between benign and malig-
nant focal pancreatic masses or locoregional lymph nodes
based on the EUS appearance is however difﬁcult and fre-
quently requires EUS-FNA for conﬁrmation of malignancy.3,4
The accuracy of EUS-FNA for the diagnosis of pancreatic car-
cinoma is reported to be 80–95%,5 with a pooled sensitivity
and speciﬁcity of 85% and 98%, respectively, in a recently
published meta-analysis.2
Furthermore, color ﬂow imaging in Doppler or power
Doppler mode can be used to describe the peripancreatic
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vasculature. Use of contrast enhancement in EUS (based on
second-generation microbubble ultrasound contrast agents)
has been shown to improve the characterization of the
vasculature inside the lesion of interest, to better delineate
benign from malignant pathology and to aid in staging
and directing therapeutic procedures.6 Thus, pancreatic ade-
nocarcinomas are hypovascular, whereas pseudotumoral
chronic pancreatitis or neuroendocrine tumors are either iso-
vascular or hypervascular as compared with the surrounding
parenchyma.1
Real-time sonoelastography performed during EUS is a
promising imaging technique with a high accuracy for the dif-
ferential diagnosis of solid pancreatic tumors by assessing tissue
hardness, which might provide clinical utility in the diagnosis
of pancreatic disorders.7 Knowing that malignant tissues are
generally harder than normal surrounding tissue, elastography
might provide interesting clinical information to help dis-
tinguish benign from malignant tissue based on speciﬁc tissue
consistency. EUS elastography was also reported to be useful for
the differentiation of focal pancreatic masses, especially in
pseudotumoral chronic pancreatitis and pancreatic cancer, es-
pecially in the presence of false negative EUS-guided FNA re-
sults and a strong suspicion of pancreatic cancer.8 The accuracy
of EUS-FNA for the diagnosis of pancreatic adenocarcinoma is
reported to be 80–95%, depending on the type of the needle
(cytological vs. histological), the technique used (with or
without suction), the presence or absence of a cytopathologist
in the examination room, etc. The results of initial studies were
recently validated in a large multicentric study, indicating high
values for sensitivity, speciﬁcity, negative predictive value,
positive predictive value, and overall accuracy (93.4%, 66.0%,
92.5%, 68.9%, and 85.4%, respectively).9
Key Learning Points/Tips and Tricks
• The recent development of low mechanical index contrast
harmonic EUS imaging offers hope for improved differ-
ential diagnosis, accurate staging, and monitoring of anti-
angiogenic treatment in pancreatic adenocarcinoma.
• Real-time sonoelastography performed during EUS is a
promising imaging technique with high accuracy for the
differential diagnosis of solid pancreatic tumors, based on
the assessment of tissue hardness.
• Differential diagnosis between benign and malignant focal
pancreatic masses is nevertheless difﬁcult and frequently
requires EUS-FNA for conﬁrmation of the malignancy.
Complications and Risk Factors
• Complication rate for EUS without the ﬁne needle aspir-
ation is approximately one in two thousand. This is similar
to the complication rate of other advanced endoscopy
procedures, especially when general anesthesia is
associated.
• Several studies have reported a low rate of EUS-FNA com-
plications, which include: bleeding (0–1.3%),10–12 perfor-
ation (0–0.4%),10,11 infection (0.3%),10,11 and pancreatitis
(1–2%).10 The risk of bacteremia is low and prophylactic
antibiotics are not recommended except for EUS-FNA of
pancreatic cystic lesions.13,14 Seeding of malignant cells
along the FNA needle tract has been reported in EUS-FNA
of pancreatic lesions15; however, the risk of this occurring is
lower than in percutaneous biopsy.16
Scripted Voiceover
Time (min:sec) Voiceover text
00:00 Transabdominal
ultrasound
A 59-year-old woman was
admitted for jaundice and
moderate epigastric pain.
Abdominal ultrasonography
showed a suspicious mass
within the head of the
pancreas.
00:18 Endoscopic ultrasound:
gray-scale, color Doppler,
power Doppler
Linear endoscopic ultrasound
(EUS) was performed for
detailed visualization of the
pancreas. EUS revealed a
hypoechoic, inhomogeneous
mass, 2 cm in diameter, at
the level of the pancreatic
head, poorly deﬁned and
obstructing the pancreatic duct
and bile duct. Grayscale
examinations are followed by
color Doppler and power
Doppler examinations, which
show collateral vessels, but
almost no Doppler signals
inside the mass. The mass is
adjacent to the mesenteric
conﬂuence and splenic
vessels, but does not inﬁltrate
them or the celiac trunk. EUS
also shows multiple lymph
nodes (round-oval),
hypoechoic, up-to 1.5 cm
diameter, located in the
peripancreatic area.
1:39 Contrast-enahencd EUS Then we performed low
mechanical index contrast-
enhanced endoscopic
ultrasound. After injection of
the contrast agent (4.8 ml
Sono-Vue), we observe
enhancement of the
peritumoral tissues, with a
hypoenhanced appearance
(discrete uptake of the
contrast) at the level of the
pancreatic mass in the early
arterial phase and the late
venous phase.
2:10 Real-time sono-
elastography
EUS elastography shows a hard
mass, as compared with
adjacent tissues, suggestive of
a malignant tumor mass.
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2:20 EUS-guided Because differential diagnosis
between benign and malignant
focal pancreatic masses based
on the EUS appearance is
difﬁcult, we continued the
examination with EUS-guided
ﬁne needle aspiration for
conﬁrmation of malignancy.
We performed three passes
followed by cytology exam of
the slides, indicating a clear-
cut diagnosis of pancreatic
adenocarcinoma. We thus
demonstrated the usefulness
of diagnosing a small
pancreatic cancer using EUS,
contrast-enhancement, real-
time sono-elastography and
EUS-guided ﬁne-needle
aspiration (FNA), which
allowed surgery and
postoperative staging.
3:18 Surgical sample This is a picture of the
postoperative tumor, which
was staged as pT3N1M0.
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